Arquivos do dia: Agosto 1, 2022
Revisão sistemática | Testes rápidos de antígeno para diagnóstico de infecção por SARS-CoV-2.
1 Ago, 2022 | 15:23hRapid, point‐of‐care antigen tests for diagnosis of SARS‐CoV‐2 infection – Cochrane Library
Resumo: How accurate are rapid antigen tests for diagnosing COVID-19? – Cochrane Library
M-A | Tratamento anti-hipertensivo na prevenção de doenças cardiovasculares em pessoas com e sem diabetes tipo 2.
1 Ago, 2022 | 15:22hComentários:
No justification for bespoke antihypertensive intervention in type 2 diabetes – medwire News
Blood pressure control according to type 2 diabetes status – The Lancet Diabetes & Endocrinology (necessário cadastro gratuito)
Comentário no Twitter
Online—Blood pressure-lowering treatment for prevention of major #cardiovascular diseases in people with and without type 2 #diabetes: an individual participant-level data meta-analysis https://t.co/AmNxyW9Via #T2D #BloodPressure #hypertension #openaccess pic.twitter.com/NfdLktZXai
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) July 25, 2022
Posicionamento científico | Levedura de arroz vermelho para dislipidemias e redução do risco cardiovascular.
1 Ago, 2022 | 15:21h
Diretriz ASTRO | Radioterapia para glioma difuso IDH-mutante grau 2 e grau 3.
1 Ago, 2022 | 15:20h
Diretriz | Carcinoma de tireoide diferenciado pediátrico.
1 Ago, 2022 | 15:18h
Revisão sistemática | Agentes antiplaquetários e anticoagulantes em pacientes com hipertensão.
1 Ago, 2022 | 15:17hAntiplatelet agents and anticoagulants for hypertension – Cochrane Library
Resumo: Antiplatelet agents and anticoagulants for high blood pressure – Cochrane Library
Comentário no Twitter
Do #antiplatelet agents & #anticoagulants improve outcomes in people with #hypertension?
Our newly updated @CochraneLibrary review looks at the evidence of 6 RCTs involving more than 61,000 participants: https://t.co/zaXP4YLg4n#CochraneEvidence #blogshot pic.twitter.com/X1DK2NTCtb
— Cochrane Hypertension (@CochraneHTN) July 28, 2022
M-A | Ocorrência de câncer de pulmão após episódio de tuberculose.
1 Ago, 2022 | 15:16h
Estudo de coorte | Impacto do vazamento peridispositivo em desfechos de 5 anos após fechamento do apêndice atrial esquerdo.
1 Ago, 2022 | 15:14hImpact of Peridevice Leak on 5-Year Outcomes After Left Atrial Appendage Closure – Journal of the American College of Cardiology (link para o resumo – $ para o texto completo)
Comentário: Peridevice Leaks After LAA Occlusion Signal Poorer 5-Year Outcomes – TCTMD
Grande estudo observacional sugere que antipsicóticos injetáveis de ação longa estão associados a desfechos melhores do que antipsicóticos orais em pessoas com esquizofrenia.
1 Ago, 2022 | 15:12hComentário convidado: Improving Outcomes in Schizophrenia—A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness – JAMA Network Open
Conteúdos relacionados:
Long-term Outcomes of Early Use of Long-Acting Injectable Antipsychotics in Schizophrenia – The Journal of Clinical Psychiatry (link para o resumo – $ para o texto completo)
Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis – The Lancet (link para o resumo – $ para o texto completo)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link para o resumo – $ para o texto completo)
Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studies – The Lancet Psychiatry (link para o resumo – $ para o texto completo)
Comentário no Twitter
This case series of people with schizophrenia found long-acting injectable antipsychotics were associated with less disease relapse and hospitalization vs oral antipsychotics, w/o an increased risk of adverse events. @Esther_CSMPRHKU @HKUPharm @hkumed https://t.co/ZiPkV4lSk0
— JAMA Network Open (@JAMANetworkOpen) July 28, 2022
Estudo de coorte | Avaliação do risco de segundo câncer primário entre homens que receberam radioterapia vs. cirurgia para tratamento de câncer de próstata.
1 Ago, 2022 | 15:10h
Comentário no Twitter
In this cohort study of patients with localized prostate cancer, radiotherapy was associated with a small increase in the risk of developing a second primary cancer. https://t.co/YsrNo3FKwM
— JAMA Network Open (@JAMANetworkOpen) July 28, 2022